Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ

Previous study has suggested that the FABP5-PPARγ-signalling transduction pathway gradually replaces the androgen receptor activated pathway in promoting malignant progression of castration-resistant prostate cancer (CRPC) cells. To interfere with this newly discovered FABP5-related signalling pathw...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Jameel, Waseem, Gou, Xiaojun, Jin, Xi, Zhang, Jiacheng, Wei, Qiang, Ai, Jianzhong, Li, Hong, Al-Bayati, Asmaa, Platt-Higgins, Angela, Pettitt, Andrew, Rudland, Philip S., Ke, Youqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584209/
https://www.ncbi.nlm.nih.gov/pubmed/31258834
http://dx.doi.org/10.18632/genesandcancer.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584209/
https://www.ncbi.nlm.nih.gov/pubmed/31258834
http://dx.doi.org/10.18632/genesandcancer.192

Ejemplares similares